Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock
暂无分享,去创建一个
[1] J. Tijssen,et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. , 2017, Journal of the American College of Cardiology.
[2] Sunil V. Rao,et al. A team‐based approach to patients in cardiogenic shock , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] S. Hall,et al. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device. , 2016, The American journal of cardiology.
[4] N. Chou,et al. Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation , 2016, Scientific Reports.
[5] P. Leprince,et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock , 2016, Intensive Care Medicine.
[6] S. Lage,et al. Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry , 2016, Arquivos brasileiros de cardiologia.
[7] D. Burkhoff,et al. Hemodynamics of Mechanical Circulatory Support. , 2015, Journal of the American College of Cardiology.
[8] Gene Kim,et al. The Subclavian Intraaortic Balloon Pump: A Compelling Bridge Device for Advanced Heart Failure. , 2015, The Annals of thoracic surgery.
[9] Joshua N. Baker,et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[10] J. Davies,et al. Intra-aortic Balloon Pump Therapy for Acute Myocardial Infarction: A Meta-analysis. , 2015, JAMA internal medicine.
[11] J. Goldstein,et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation o , 2015, Journal of the American College of Cardiology.
[12] G. Couper,et al. Extracorporeal Membrane Oxygenation in Adults With Cardiogenic Shock , 2015, Circulation.
[13] S. Bangalore,et al. Abstract 13061: Trends in Incidence, Management and Outcomes of Heart Failure Patients with Cardiogenic Shock , 2014 .
[14] P. Leprince,et al. Intra-Aortic Balloon Pump Effects on Macrocirculation and Microcirculation in Cardiogenic Shock Patients Supported by Venoarterial Extracorporeal Membrane Oxygenation* , 2014, Critical care medicine.
[15] J. Hochman,et al. Mechanical circulatory support in cardiogenic shock. , 2014, European heart journal.
[16] D. Kolte,et al. Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States , 2014, Journal of the American Heart Association.
[17] W. O’Neill,et al. The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry , 2013, Journal of interventional cardiology.
[18] M. Loebe,et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. , 2013, JACC. Heart failure.
[19] Michael F Swartz,et al. Impella to Unload the Left Ventricle During Peripheral Extracorporeal Membrane Oxygenation , 2013, ASAIO journal.
[20] G. Gensini,et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. , 2013, American heart journal.
[21] James O. Mudd,et al. Mechanical circulatory support for right ventricular failure. , 2013, JACC. Heart failure.
[22] B. Griffith,et al. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. , 2013, The Journal of thoracic and cardiovascular surgery.
[23] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[24] N. Parakh. Intraaortic balloon support for myocardial infarction with cardiogenic shock , 2012 .
[25] V. Jeevanandam,et al. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. , 2012, The Journal of thoracic and cardiovascular surgery.
[26] D. Atar,et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. , 2012, European heart journal.
[27] M. Ishihara,et al. Should We Emergently Revascularize Occluded Coronaries for Cardiac Arrest?: Rapid-Response Extracorporeal Membrane Oxygenation and Intra-Arrest Percutaneous Coronary Intervention , 2012, Circulation.
[28] Joonho Jung,et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. , 2012, Resuscitation.
[29] J. Henriques,et al. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations , 2012, Heart.
[30] A. Takahashi,et al. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. , 2012, The Annals of thoracic surgery.
[31] Sarabjeet Singh,et al. Cardiovascular Outcomes Using Intra-Aortic Balloon Pump in High-Risk Acute Myocardial Infarction With or Without Cardiogenic Shock , 2012, Journal of cardiovascular pharmacology and therapeutics.
[32] M. Drazner,et al. Successful use of the TandemHeart percutaneous ventricular assist device as a bridge to recovery for acute cellular rejection in a cardiac transplant patient. , 2011, Transplantation proceedings.
[33] M. Hochadel,et al. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[34] James W Long,et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. , 2011, The Journal of thoracic and cardiovascular surgery.
[35] P. Loyalka,et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. , 2011, Journal of the American College of Cardiology.
[36] Wei Hu,et al. Intra-Aortic Balloon Pump Improves Clinical Prognosis and Attenuates C-Reactive Protein Level in Acute STEMI Complicated by Cardiogenic Shock , 2010, Cardiology.
[37] N. Doll,et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. , 2010, The Journal of thoracic and cardiovascular surgery.
[38] K. Werdan,et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome* , 2010, Critical care medicine.
[39] P. Serruys,et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. , 2009, European heart journal.
[40] T. Edvardsen,et al. Intra‐aortic balloon counterpulsation as a bridge to heart transplantation does not impair long‐term survival , 2009, European journal of heart failure.
[41] J. Gore,et al. Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective , 2009, Circulation.
[42] R. Thiagarajan,et al. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. , 2009, The Annals of thoracic surgery.
[43] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.
[44] J. Tijssen,et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? , 2008, European heart journal.
[45] N. Chi,et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis , 2008, The Lancet.
[46] Pascal Leprince,et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.
[47] Judith S. Hochman,et al. Cardiogenic Shock: Current Concepts and Improving Outcomes , 2008, Circulation.
[48] J. Tijssen,et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. , 2007, American heart journal.
[49] J. Tijssen,et al. Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. , 2007, The American journal of cardiology.
[50] D. Burkhoff,et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.
[51] S. Assmann,et al. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. , 2003, American heart journal.
[52] G. Schuler,et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.
[53] J. Gore,et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. , 2001, American heart journal.
[54] A. Jacobs,et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction : A report from the shock trial Registry , 2000 .
[55] R. Califf,et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1997, Journal of the American College of Cardiology.
[56] E. Ohman,et al. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. , 1997, Journal of the American College of Cardiology.
[57] E. Bates,et al. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. , 1994, Chest.
[58] R. Califf,et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. , 1992, Journal of the American College of Cardiology.
[59] S. Moulopoulos,et al. Intraaortic balloon assistance in intractable cardiogenic shock. , 1986, European heart journal.
[60] W. Cohn,et al. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). , 2008, Texas Heart Institute journal.
[61] W. Cohn,et al. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation. , 2008, Texas Heart Institute journal.
[62] M. Gotsman,et al. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. , 1993, European heart journal.